Cost-effectiveness analysis of the Parkinson’s KinetiGraph and clinical assessment in the management of Parkinson's disease

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Medical Economics

• Publication date

  2022-05-20

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1080/13696998.2022.2080437PMID 35593687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation study

  2021cited by this paper
• A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson’s disease using an ambulatory monitor

  2021cited by this paper
• Cost-Benefit Analysis and the environment: The time horizon is of the essence

  2021cited by this paper
• The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review

  2021cited by this paper
• A blinded, controlled trial of objective measurement in Parkinson’s disease

  2020cited by this paper
• More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson’s Disease Based on Parkinson’s KinetiGraph (PKG)

  2020cited by this paper
• Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s Disease

  2020cited by this paper
• Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®

  2020cited by this paper
• Parkinson’s disease: summary of updated NICE guidance

  2019cited by this paper
• PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease

  2019cited by this paper
• Short‐ and long‐term cost and utilization of health care resources in Parkinson's disease in the UK

  2018cited by this paper
• Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

  2018cited by this paper
• Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2018cited by this paper
• The Emerging Evidence of the Parkinson Pandemic

  2018cited by this paper
• Levodopa Effect and Motor Function in Late Stage Parkinson’s Disease

  2018cited by this paper
• Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort

  2018cited by this paper
• Non-motor features of Parkinson disease

  2017cited by this paper
• Personalized medicine in Parkinson's disease: Time to be precise

  2017cited by this paper
• A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

  2015cited by this paper
• Parkinson's disease and risk of mortality: meta‐analysis and systematic review

  2014cited by this paper
• Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson’s disease

  2013cited by this paper
• Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials

  2012cited by this paper
• The clinically important difference on the unified Parkinson's disease rating scale.

  2010cited by this paper
• Multi-state models for the analysis of time-to-event data

  2009cited by this paper
• Rate of clinical progression in Parkinson's disease. A prospective study

  2007cited by this paper
• Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

  2007cited by this paper
• Non-motor symptoms of Parkinson's disease: diagnosis and management.

  2006cited by this paper
• Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

  2005cited by this paper

• Mobile health technologies for the management of Parkinson’s disease

  2025cites this paper
• Analysis of factors affecting hospitalization costs in Parkinson disease patients: A retrospective study based on 848 cases

  2025cites this paper
• Movement Disorders and Smart Wrist Devices: A Comprehensive Study

  2025cites this paper
• Economic evaluation of mHealth solutions in PD: where do we stand?

  2025cites this paper
• Perspectives on digital health and advanced treatment referral in Parkinson’s care among Danish neurologists: a mixed methods study

  2025cites this paper
• Self-Management Systems for Patients and Clinicians in Parkinson’s Disease Care: A Scoping Review

  2024cites this paper
• Parkinson’s Kinetigraph for Wearable Sensor Detection of Clinically Unrecognized Early-Morning Akinesia in Parkinson’s Disease: A Case Report-Based Observation

  2024cites this paper
• Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.

  2024cites this paper
• Evaluation of the Parkinson’s Remote Interactive Monitoring System in a Clinical Setting: Usability Study

  2023cites this paper
• The ‘PD Warrior’ exercise programme improves motor outcomes and quality of life in patients with early Parkinson disease: results of a pilot study

  2023cites this paper
• Overview on wearable sensors for the management of Parkinson’s disease

  2023cites this paper
• Molecular Docking of Zingerone and Gamma-Mangostin to Inhibit MAO-B and Catechol-O-Methyltransferase (COMT) in the Treatment of Parkinson’s Disease

  2022cites this paper